Artialis Report issue

Foundation Phase 4
Founded: Liège Belgium (2010)

Organization Overview

First Clinical Trial
2014
NCT02909621
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Artialis

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 12